Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Alcoholic Hepatitis Treatment Market from 2024 to 2025?

The market size for treatment of alcoholic hepatitis has seen significant growth over the years. It is projected to rise from $3.2 billion in 2024 to $3.44 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. This growth during the historical period can be linked to the high incidence of alcohol misuse, enhanced awareness and diagnosis, governmental efforts to tackle alcoholism, increased spending on healthcare, and campaigns aiming at public health.

What Is the Projected Market Size of the Alcoholic Hepatitis Treatment Market?

Expectations for the alcoholic hepatitis treatment market predict a sizable increase over the coming years. The value is forecasted to rise to $4.82 billion by 2029, with a compound annual growth rate (CAGR) of 8.8%. This anticipated growth within the forecast period is owing to factors like the emergence of novel therapies and drug pipeline, precision medicine strategies, expanding knowledge of disease pathogenesis, escalating attention on liver health, and public health policies combatting alcohol misuse. Some major trends projected for the forecast period include personalized medicine practices, trends in liver transplantation, advancements in telemedicine and remote monitoring, collaborative research ventures, and groundbreaking drug solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12104&type=smp

Who are the Major Competitors in the Alcoholic Hepatitis Treatment Market Outlook?

Major companies operating in the alcoholic hepatitis treatment market include AbbVie Inc., Gilead Sciences Inc., Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, F. Hoffmann-La Roche Ltd, Sanofi S.A., Novartis AG, Amgen Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim International GmbH, Mallinckrodt Pharmaceuticals, Intercept Pharmaceuticals Inc., Madrigal Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., DURECT Corporation, Viking Therapeutics Inc., CymaBay Therapeutics Inc., Genfit SA, BioVie Inc., Akero Therapeutics Inc., Zydus Cadila, Dr. Reddy’s Laboratories Ltd.

What Is Fueling Growth in the Alcoholic Hepatitis Treatment Market?

The rising incidence of liver diseases due to alcohol intake is projected to drive the expansion of the market for alcoholic hepatitis treatments. When the liver’s function becomes impaired as a result of alcoholic liver disease, it affects various bodily functions, including blood detoxification and bile production for digestive aid. Therapies for alcoholic hepatitis are used to manage liver inflammation in some people diagnosed with this condition. Those with advanced alcoholic hepatitis may need to be treated in a hospital setting. For example, the Office for Health Improvement and Disparities, a government body in the UK, released statistics in April 2024 depicting 10,593 premature deaths from liver disease in 2022, with 6,664 of them being male and 3,929 being female. The fiscal year ending in 2023 also witnessed 85,665 hospitalizations due to liver disease in England, averaging 155.2 individuals per 100,000 population. These figures included 27,085 admissions specifically for alcoholic liver disease, equating to a rate of 49.4 per 100,000 population. Hence, the surge in liver diseases caused by alcohol is the key driver of the alcoholic hepatitis treatment market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12104&type=smp

Which Alcoholic Hepatitis Treatment Market Segments Are Growing the Fastest?

The alcoholic hepatitis treatment market covered in this report is segmented –

1) By Treatment: Drug Treatment, Stem Cell Therapy

2) By Drug Class: Corticosteroids, Hemorheologic Agents, Monoclonal Antibodies, Anabolic Steroids, Other Drug Classes

3) By Route Of Administration: Oral, Injectable

4) By Application: Hospital, Clinic, Private Treatment Center

Subsegments:

1) By Drug Treatment: Corticosteroids, Pentoxifylline, Other Immunosuppressants

2) By Stem Cell Therapy: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy

Which Industry Trends Are Shaping the Future of the Alcoholic Hepatitis Treatment Market?

Innovations in product development are becoming a significant trend in the market for alcoholic hepatitis treatment. Firms in this industry are striving to create new, innovative products to maintain their competitive edge in the market. Take the example of Roche Holding AG, a healthcare company based in Switzerland, which in July 2022, introduced the Elecsys HCV Duo, a groundbreaking dual antibody and antigen hepatitis C virus diagnostic test. This test allows simultaneous and independent determination of both the antigen and the antibody status of the hepatitis C virus (HCV) from a single human plasma or serum sample. It’s useful for detecting patients with chronic infection symptoms that could lead to conditions such as liver cancer, and for identifying early-stage infections. Since the core antigen appears early during the course of infection and is used as an indicator of continuous viral replication, this combined detection of HCV’s core antibodies and antigen allows doctors to diagnose active HCV more quickly than using antibody-only assays.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/alcoholic-hepatitis-treatment-global-market-report

Which Countries Are Leading the Alcoholic Hepatitis Treatment Market?

North America was the largest region in the alcoholic hepatitis treatment market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12104

This Report Delivers Insight On:

1. How big is the alcoholic hepatitis treatment market, and how is it changing globally?

2. Who are the major companies in the alcoholic hepatitis treatment market, and how are they performing?

3. What are the key opportunities and risks in the alcoholic hepatitis treatment market right now?

4. Which products or customer segments are growing the most in the alcoholic hepatitis treatment market?

5. What factors are helping or slowing down the growth of the alcoholic hepatitis treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model